Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP729163.RAcfbrFH36oW1e7t6eQbakDVLJ0PK-ignFD0oEj8E7oEM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP729163.RAcfbrFH36oW1e7t6eQbakDVLJ0PK-ignFD0oEj8E7oEM130_assertion type Assertion NP729163.RAcfbrFH36oW1e7t6eQbakDVLJ0PK-ignFD0oEj8E7oEM130_head.
- NP729163.RAcfbrFH36oW1e7t6eQbakDVLJ0PK-ignFD0oEj8E7oEM130_assertion wasGeneratedBy ECO_0000203 NP729163.RAcfbrFH36oW1e7t6eQbakDVLJ0PK-ignFD0oEj8E7oEM130_provenance.
- NP729163.RAcfbrFH36oW1e7t6eQbakDVLJ0PK-ignFD0oEj8E7oEM130_assertion wasDerivedFrom befree-20150227 NP729163.RAcfbrFH36oW1e7t6eQbakDVLJ0PK-ignFD0oEj8E7oEM130_provenance.
- NP729163.RAcfbrFH36oW1e7t6eQbakDVLJ0PK-ignFD0oEj8E7oEM130_assertion SIO_000772 20805990 NP729163.RAcfbrFH36oW1e7t6eQbakDVLJ0PK-ignFD0oEj8E7oEM130_provenance.
- NP729163.RAcfbrFH36oW1e7t6eQbakDVLJ0PK-ignFD0oEj8E7oEM130_assertion evidence source_evidence_literature NP729163.RAcfbrFH36oW1e7t6eQbakDVLJ0PK-ignFD0oEj8E7oEM130_provenance.
- NP729163.RAcfbrFH36oW1e7t6eQbakDVLJ0PK-ignFD0oEj8E7oEM130_assertion description "[The loss of AP-2alpha and increased activity of cAMP-responsive element binding (CREB) protein are two hallmarks of malignant progression of cutaneous melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP729163.RAcfbrFH36oW1e7t6eQbakDVLJ0PK-ignFD0oEj8E7oEM130_provenance.